Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival

Transplantation

Volumn 75, Issue 4, 2003, Pages 521-528

  DePaz, Hector A ^a   Oluwole, Olakunle O ^a   Adeyeri, Ayotunde O ^a   Witkowski, Piotr ^b   Jin, Ming Xing ^a   Hardy, Mark A ^a   Oluwole, Soji F ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOCYTE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; EVALUATION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HYPOTHESIS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; NEUROBLAST; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEART TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; RATS; RATS, INBRED ACI; RATS, INBRED LEW; RATS, INBRED WF; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037468388     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000048380.84355.4A     Document Type: Article

References (30)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-296.
2. Steinman RM, Inaba K, Turley S, et al. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol 1999; 60(7): 562-567.
3. Garrovillo M, Ali A, Oluwole SF. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Transplantation 1999; 68: 1827-1833.
4. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex [MHC] class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185: 541-550.
5. Ali A, Garrovillo M, Jin MX, et al. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells. Transplantation 2000; 69: 221-226.
6. Oluwole OO, DePaz HA, Gopinathan R, et al. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 2001; 50: 1546-1552.
7. Khoury SJ, Gallon L, Chen W, et al. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 1995; 182: 357-366.
8. Matzinger P, Guerder S. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 1989; 338: 74-76.
9. Thomson AW, Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 1999; 68: 1-8.
10. Reid SD, Penna G, Adorini L. The control of T cell responses by dendritic cell subsets. Curr Opin Immunol 2000; 12: 114-121.
11. Jonuleit H, Schmitt E, Schuler G, et al. Induction of interleukin 10-producing, non-proliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213-1222.
12. Clare-Salzler MJ, Brooks J, Chai A, et al. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992; 90: 741-748.
13. Feili-Hariri M, Dong X, Alber SM, et al. Immunotherapy of NOD mice with bone marrow derived dendritic cells. Diabetes 1999; 48: 2300-2308.
14. + cells in whole bone marrow facilitate the engraftment of hemopoietic stem cells across allogeneic barriers. Immunity 1999; 11: 579-590.
15. Lu L, McCaslin D, Starzl TE, et al. Bone marrow derived dendritic cell progenitors (NLDC-145+, Class II+, B7-1dim, B7-1-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60: 1539-1545.
16. Lutz MB, Kukutsch NA, Menges M, et al. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol 2000; 30: 1048-1052.
17. Ono K, Lindsey BS. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surgery 1969; 57: 225-229.
18. Oluwole SF, Chowdhury NC, Ingram M, et al. Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class I peptide with the dominant epitope: differential analysis of regulatory cytokines in the lymphoid and intragraft compartments. Transplantation 1999; 68: 418-429.
19. Fairchild PJ, Waldmann H. Dendritic cells and prospects for transplantation tolerance. Curr Opin Immunol 2000; 12: 528-535.
20. Garrovillo M, Ali A, DePaz HA, et al. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells. Am J Transplantation 2001; 1: 129-137.
21. Ali A, Garrovillo M, Oluwole OO, et al. Mechanisms of acquired thymic tolerance: induction of transplant tolerance by adoptive transfer of in vivo alloMHC peptide activated T cells. Transplantation 2001; 71: 1442-1448.
22. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000; 30: 1813-1822.
23. Fu F, Li Y, Qian S, et al. Co-stimulatory molecule-deficient dendritic cell progenitors (MHC Class II+, B7-1dim, B7-1-) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 1996; 62: 659-665.
24. Lu L, Li W, Fu F, et al. Blockade of the CD40-C40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64: 1808-1815.
25. Hayamizu K, Huie P, Sibley RK, et al. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation 1998; 66: 1285-1291.
26. Saas P, Tiberghien P. Dendritic cells: to where do they lead? Transplantation 2002; 73: S12-S15.
27. Fanger NA, Maliszewski CR, Schooley K, et al. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med 1999; 190: 1155-1165.
28. Lu L, Qian S, Hershberger PA, et al. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997; 158: 5476-5684.
29. Huang FG, Platt N, Wykes M, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000; 191: 435-493.
30. Dhodapkar MV, Steinman RM, Krasovsky J, et al. Antigen-specific inhibition of effector T cell junction in humans after injection of immature dendritic cells. J Exp Med 2001; 193: 233-238.